Evidence map›Paper›PMID 28912804›Full record

ArticleGastroenterology research and practice2017

Assessment of Nutritional Status, Digestion and Absorption, and Quality of Life in Patients with Locally Advanced Pancreatic Cancer.

J E Witvliet-van Nierop, C M Lochtenberg-Potjes, N J Wierdsma, H J Scheffer, G Kazemier, K Ottens-Oussoren, M R Meijerink, M A E de van der Schueren

Registry-linked trialAbstract read
In one paragraph

Article in Gastroenterology research and practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01939665 (PANFIRE - Pilot-study), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01939665 phase1 / phase2completednot on this map

PANFIRE - Pilot-study: Non-thermal Ablation Using Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma - a Phase I Clinical Trial

TypeinterventionalSponsorAmsterdam UMC, location VUmcRan2013 to 2016Enrolled50ConditionsLocally Advanced Pancreatic Carcinoma (LAPC), Non-metastasized Unresectable Pancreatic Carcinoma, Pancreatic CancerArmsNanoKnife "Irreversible electroporation (IRE)"
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

J E Witvliet-van NieropDepartment of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, Netherlands.ORCID 0000-0002-8738-2229
C M Lochtenberg-PotjesDepartment of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, Netherlands.
N J WierdsmaDepartment of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, Netherlands.
H J SchefferDepartment of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands.
G KazemierDepartment of Surgery, VU University Medical Center, Amsterdam, Netherlands.
K Ottens-OussorenDepartment of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, Netherlands.
M R MeijerinkDepartment of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands.
M A E de van der SchuerenDepartment of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimTo provide a comprehensive quantitative assessment of nutritional status, digestion and absorption, and quality of life (QoL) in patients with locally advanced pancreatic cancer (LAPC).

methodsSixteen patients with LAPC were prospectively assessed for weight loss (WL), body mass index (BMI), fat-free mass index (FFMI), handgrip strength (HGS), dietary macronutrient intake, serum vitamin levels, resting and total energy expenditure (REE and TEE, indirect calorimetry), intestinal absorption capacity and fecal losses (bomb calorimetry), exocrine pancreatic function (fecal elastase-1 (FE1)), and gastrointestinal quality of life (GIQLI).

resultsTwo patients had a low BMI, 10 patients had WL > 10%/6 months, 8 patients had a FFMI < P10, and 8 patients had a HGS < P10. Measured REE was 33% higher (

conclusionPatients with LAPC have a severely impaired nutritional status, most likely as a result of an increased REE and malabsorption due to exocrine pancreatic insufficiency. The trial is registered with PANFIRE clinicaltrials.gov NCT01939665.

Identifiers

PMID28912804
PMCPMC5585661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.